Literature DB >> 9781350

Identification and analysis of a CA(2+)-dependent lactoferrin receptor in rat liver. Lactoferrin binds to the asialoglycoprotein receptor in a galactose-independent manner.

D D McAbee1, D J Bennatt, Y Y Ling.   

Abstract

We identified a 45 kDa Ca(2+)-dependent Lf binding protein on rat hepatocytes. Dithiobis(sulfosuccimidylproprionate) (DTSSP)-crosslinked 125I-Lf to a 45 kDa adduct in a Ca(2+)-dependent manner on intact cells. The 125I-labeled crosslinked complexes were absent when either surface-bound 125I-Lf was stripped prior to crosslinking or an excess of unlabeled Lf was included in the DTSSP reaction. Triton X-100 extracts of hepatocyte membrane ghosts were chromatographed on Lf-agarose, and a 45 kDa polypeptide (p45) was eluted by EGTA. Anti-p45 sera blocked vigorously 125I-Lf endocytosis to intact rat hepatocytes, confirming that p45 functions as the Ca(2+)-dependent Lf receptor on hepatocytes. Two tryptic fragments of p45 showed 100% identity with internal sequences (Leu121-->Lys126 and Phe198-->Lys220) of the major subunit (RHL-1) of the rat asialoglycoprotein receptor. Antisera against p45 and RHL-1 crossreacted equally well with each protein, and asialoorosomucoid blocked the binding of 125I-Lf to hepatocytes. We did not detect the minor subunits (RHL-2/3) of the rat asialoglycoprotein receptor in p45 preparations from Triton X-100-extracts of hepatocytes, and 125I-Lf bound to immobilized RHL-1 but not to RHL-2/3. Exoglycosidases were used to remove terminally-exposed NeuNAc and alpha- and beta-Gal from bovine Lf glycans, and lectin blotting confirmed that glycosidase-treated Lfs lacked detectable terminal Gal. Unexpectedly, deglycosylated Lf exhibited no loss in its ability to compete with unmodified Lf for binding to isolated hepatocytes. Moreover, beta-lactose but not sucrose competed vigorously for 125I-Lf endocytosis by hepatocytes, indicating that Lf binds at or near the carbohydrate-recognition domain of RHL-1. We conclude that RHL-1 is the Ca(2+)-dependent Lf receptor on hepatocytes and that it binds Lf in a Gal-independent manner.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781350

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma.

Authors:  Minyan Wei; Xiucai Guo; Liuxiao Tu; Qi Zou; Qi Li; Chenyi Tang; Bao Chen; Yuehong Xu; Chuanbin Wu
Journal:  Int J Nanomedicine       Date:  2015-08-12

2.  In vitro and in vivo antitumor effects of lupeol-loaded galactosylated liposomes.

Authors:  Jun Zhang; Xixi Hu; Guohua Zheng; Hui Yao; Huali Liang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 3.  Potential Use of Biological Proteins for Liver Failure Therapy.

Authors:  Kazuaki Taguchi; Keishi Yamasaki; Hakaru Seo; Masaki Otagiri
Journal:  Pharmaceutics       Date:  2015-08-31       Impact factor: 6.321

Review 4.  Efficient hepatic delivery of drugs: novel strategies and their significance.

Authors:  Nidhi Mishra; Narayan Prasad Yadav; Vineet Kumar Rai; Priyam Sinha; Kuldeep Singh Yadav; Sanyog Jain; Sumit Arora
Journal:  Biomed Res Int       Date:  2013-10-28       Impact factor: 3.411

5.  The prospects of modifying the antimicrobial properties of milk.

Authors:  A F Kolb
Journal:  Biotechnol Adv       Date:  2001-07       Impact factor: 14.227

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.